{
"id":"mk19_bb_nr_s12",
"subspecialtyId":"nr",
"title":"Multiple Sclerosis",
"jsonContent":{
"type":"section",
"id":"mk19_bb_nr_s12",
"title":{
"__html":"Multiple Sclerosis"
},
"titleNode":{
"type":"section-title",
"hlId":"38050d",
"children":[
"Multiple Sclerosis"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_nr_s12_1",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"788399",
"children":[
{
"type":"abbreviation",
"title":"multiple sclerosis",
"children":[
"MS"
]
},
" is characterized by episodes of dysfunction resulting from demyelinating lesions (plaques) in different areas of the ",
{
"type":"abbreviation",
"title":"central nervous system",
"children":[
"CNS"
]
},
" (brain; brainstem, including optic nerve; or spinal cord) at different times."
]
},
{
"type":"p",
"hlId":"523b19",
"children":[
"Clinical course follows one of three basic patterns:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"0c565b",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Relapsing-remitting:"
]
},
" Clinical episodes of neurologic dysfunction, typically lasting weeks before improving, that may lead to the accumulation of disability."
]
},
" ",
{
"type":"list-item",
"hlId":"b93acc",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Secondary progressive disease:"
]
},
" Disappearance of evidence of clinical relapses in the relapsing-remitting form and by progressive disability."
]
},
" ",
{
"type":"list-item",
"hlId":"deb3f5",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Primary progressive disease:"
]
},
" Progressive disability accumulation from the time of disease onset."
]
},
" "
]
},
{
"type":"p",
"hlId":"74debc",
"children":[
"Patients who do not meet the full diagnostic criteria for MS after a first event have a clinically isolated syndrome. The 10-year risk for MS associated with a clinically isolated syndrome and lesions on brain MRI is 90%."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_nr_s12_inline_t1"
],
"forceOpen":true
},
{
"type":"p",
"hlId":"e274c4",
"children":[
"Diagnosis requires evidence of CNS demyelination disseminated in both space and time as demonstrated through a combination of documented clinical relapses, signs on physical examination, and the distribution of lesions on an MRI."
]
},
{
"type":"p",
"hlId":"667960",
"children":[
{
"type":"abbreviation",
"title":"cerebrospinal fluid",
"children":[
"CSF"
]
},
" may contain oligoclonal IgG bands or an elevated IgG index. CSF analysis is not necessary but may be helpful if the diagnosis remains questionable."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"cdbb16",
"children":[
"MS generally is not associated with cortical syndromes, such as aphasia and neglect."
]
},
" ",
{
"type":"list-item",
"hlId":"c1a392",
"children":[
"Migraine, microvascular ischemic disease, and head trauma may also cause white matter lesions on MRI."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_nr_s12_2",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"6c50e8",
"children":[
"Lifestyle changes that benefit patients include exercise and smoking cessation. High-dose glucocorticoids (oral or IV) speed recovery from acute exacerbations, most effectively in acute optic neuritis. ",
{
"type":"alert",
"children":[
"Treat fever and look for underlying infection before beginning glucocorticoids, because fever worsens symptoms of MS (pseudorelapse), and treatment of the underlying trigger will improve symptoms."
]
}
]
},
{
"type":"p",
"hlId":"79add8",
"children":[
"After the first attack of a clinically isolated syndrome (optic neuritis, spinal cord syndrome, or brainstemâ€“cerebellar syndrome), prescribe interferon beta, glatiramer acetate, or teriflunomide if brain imaging suggests MS."
]
},
{
"type":"p",
"hlId":"05a2ea",
"children":[
"Disease-modifying therapy in relapsing-remitting MS results in prevention of relapses and disability progression, may reduce mortality, and may prevent conversion to secondary progressive MS. Interferon beta and glatiramer acetate are often used first and are well tolerated; other agents may be more efficacious but are associated with significant adverse effects and are reserved for highly active relapsing-remitting or progressive forms of MS."
]
},
{
"type":"p",
"hlId":"eb20fd",
"children":[
"MS relapses that have no or minimal impact on function may simply be observed."
]
},
{
"type":"p",
"hlId":"7acf52",
"children":[
"Vitamin D added to interferon beta reduces the accumulation of MRI lesions and is recommended for all patients with MS. All patients should receive annual inactivated influenza vaccination and maintain their regular immunization schedule."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_bb_nr_s12_inline_t2"
],
"forceOpen":true
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"3483ae",
"children":[
"Interferon agents are contraindicated in patients with liver disease or depression."
]
},
" ",
{
"type":"list-item",
"hlId":"28a77f",
"children":[
"Pregnancy does not cause additional permanent disability in women with MS."
]
},
" ",
{
"type":"list-item",
"hlId":"c4bee8",
"children":[
"Combining glatiramer acetate with interferon beta provides no added benefit to either drug alone."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_nr_s12_3",
"title":{
"__html":"Test Yourself"
},
"titleNode":{
"type":"section-title",
"hlId":"7866cc",
"children":[
"Test Yourself"
]
},
"children":[
{
"type":"p",
"hlId":"deb315",
"class":"test",
"children":[
"A 25-year-old woman has a 2-week episode of new-onset gait ataxia, nystagmus, and dysarthria. Two years ago, she had optic neuritis. An MRI of the brain now shows brain lesions consistent with MS."
]
},
{
"type":"p",
"hlId":"9c1c6b",
"class":"test_answer",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Answer:"
]
},
" ",
"For diagnosis, choose relapsing-remitting MS. For management, select IV methylprednisolone and interferon beta."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_bb_nr_f08"
],
"forceOpen":true
}
]
}
]
},
"tablesContent":{
"mk19_bb_nr_s12_inline_t1":{
"id":"mk19_bb_nr_s12_inline_t1",
"number":1,
"bookId":"nr",
"title":{
"__html":"Study Table: Common Symptoms/Findings Associated With MS"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"ec997d",
"children":[
"Study Table: Common Symptoms/Findings Associated With MS"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ec1eb0",
"class":"col hd l",
"children":[
"Finding or Anatomical Involvement"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b5a7ad",
"class":"col hd l",
"children":[
"Description"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"545157",
"class":"cell txt l",
"children":[
"Optic neuritis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1de5f4",
"class":"cell txt l",
"children":[
"Subacute visual deficit in one eye along with pain with eye movement"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cd1482",
"class":"cell txt l",
"children":[
"Afferent pupillary defect"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fc1f55",
"class":"cell txt l",
"children":[
"Paradoxical dilation of the pupil when light is rapidly shifted from the unaffected to the affected eye"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f93317",
"class":"cell txt l",
"children":[
"Papillitis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8e3d75",
"class":"cell txt l",
"children":[
"Inflammatory changes in the retina causing a flared appearance of the optic disc"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e5e522",
"class":"cell txt l",
"children":[
"Myelitis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bda225",
"class":"cell txt l",
"children":[
"Focal inflammation within the spinal cord manifesting as sensory, autonomic, or motor symptoms below the affected spinal level"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"87ce65",
"class":"cell txt l",
"children":[
"Lhermitte sign"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"afa835",
"class":"cell txt l",
"children":[
"A shock-like sensation radiating down the spine or limbs induced by neck flexion"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"48f562",
"class":"cell txt l",
"children":[
"Bladder"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"02575d",
"class":"cell txt l",
"children":[
"Urinary frequency, urgency, or retention"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3c2128",
"class":"cell txt l",
"children":[
"Cerebellum"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"72c502",
"class":"cell txt l",
"children":[
"Ataxia and vertigo"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c5b7a5",
"class":"cell txt l",
"children":[
"Brainstem (internuclear ophthalmoplegia)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3e8432",
"class":"cell txt l",
"children":[
"Inability to adduct one eye and nystagmus in the abducting eye"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"16d1f2",
"class":"cell txt l",
"children":[
"Uhthoff phenomenon"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"38df49",
"class":"cell txt l",
"children":[
"Transient worsening of baseline neurologic symptoms with elevations of body temperature"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_bb_nr_s12_inline_t2":{
"id":"mk19_bb_nr_s12_inline_t2",
"number":2,
"bookId":"nr",
"title":{
"__html":"Study Table: Symptomatic Management in Multiple Sclerosis"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"4a1245",
"children":[
"Study Table: Symptomatic Management in Multiple Sclerosis"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9a717b",
"class":"col hd l",
"children":[
"Symptom"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"025efc",
"class":"col hd l",
"children":[
"Nonpharmacologic Management"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e9e77a",
"class":"col hd l",
"children":[
"Pharmacologic Management"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"22fa02",
"class":"cell txt l",
"children":[
"Spasticity"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e3d529",
"class":"cell txt l",
"children":[
"Physical therapy, stretching, massage therapy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"31f21d",
"class":"cell txt l",
"children":[
"Baclofen, benzodiazepines, cyclobenzaprine, tizanidine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5afebc",
"class":"cell txt l",
"children":[
"Neuropathic pain"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"51121e",
"class":"cell txt l",
"children":[
"Exercise therapy, ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"cognitive behavioral therapy",
"children":[
"CBT"
]
},
","
]
},
" mind-body therapies, physical therapy, acupuncture"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"892e0d",
"class":"cell txt l",
"children":[
"Carbamazepine, duloxetine, gabapentin, pregabalin, topiramate"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b5ff1b",
"class":"cell txt l",
"children":[
"Fatigue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"53d6f2",
"class":"cell txt l",
"children":[
"Insomnia treatment, regular exercise"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"674e48",
"class":"cell txt l",
"children":[
"Amantadine, amphetamines, armodafinil, modafinil"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"75cde5",
"class":"cell txt l",
"children":[
"Depression"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c43ada",
"class":"cell txt l",
"children":[
"Individual or group counseling"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c83fc3",
"class":"cell txt l",
"children":[
"Antidepressants (",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"serotonin-norepinephrine reuptake inhibitor",
"children":[
"SNRI"
]
},
"s,"
]
},
" ",
{
"type":"abbreviation",
"title":"selective serotonin reuptake inhibitor",
"children":[
"SSRI"
]
},
"s)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"22e5bf",
"class":"cell txt l",
"children":[
"Cognitive dysfunction"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"47ce6a",
"class":"cell txt l",
"children":[
"Cognitive rehabilitation and accommodation strategies"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"53b3fc",
"class":"cell txt l",
"children":[
"No proven therapy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"340a76",
"class":"cell txt l",
"children":[
"Mobility"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"20c28b",
"class":"cell txt l",
"children":[
"Physical and occupational therapy; use of braces, canes, rolling walkers, or electrostimulatory walk-assist devices"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d289c7",
"class":"cell txt l",
"children":[
"Dalfampridine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"868758",
"class":"cell txt l",
"children":[
"Urinary retention"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ddacd9",
"class":"cell txt l",
"children":[
"Manual pelvic pressure, intermittent catheterization"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6adf97",
"class":"cell txt l",
"children":[
"None"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"28cb69",
"class":"cell txt l",
"children":[
"Urinary urgency"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bca821",
"class":"cell txt l",
"children":[
"Bladder training, timed voiding"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9bb607",
"class":"cell txt l",
"children":[
"Solifenacin, oxybutynin, tolterodine"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
}
}
}